Phibro Animal Health | PAHC - Ebit

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.31B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	Ebit	更改		日
Align Technology	USD 178.05M		46.66M	2026-03
ANI Pharmaceuticals	USD 38.71M		9.58M	2026-03
Aurora Cannabis	CAD -35.79M		8.96M	2025-12
Bristol-Myers Squibb	USD 3.56B		90M	2026-03
Canopy Growth	CAD -12.66M		1.64M	2025-12
Corcept Therapeutics	USD -49.6M		54.09M	2026-03
Eli Lilly	USD 9.78B		792M	2026-03
Henry Schein	USD 194M		8M	2026-03
Idexx Laboratories	USD 362.59M		46.98M	2026-03
Knight Therapeutics	CAD 6.21M		3.27M	2025-12
Merck	USD -1.88B		8.12B	2026-03
Nektar Therapeutics	USD -19.09M		15.26M	2025-12
Pacira	USD 4.62M		1.43M	2026-03
Phibro Animal Health	USD 54.99M		2.36M	2025-12
Prestige Brands	USD 75.49M		7M	2026-03
Supernus Pharmaceuticals	USD -35.25M		49.07M	2026-03
Zoetis	USD 842M		7M	2026-03